Literature DB >> 1480860

Informational needs of individuals and families with hereditary cancers.

P T Kelly1.   

Abstract

Individuals and families with hereditary cancers have informational needs that differ, depending on the availability of testing for increased hereditary risk and major focus of concern (reproductive decision-making or risk to self). Cancer risk counseling helps individuals understand risk information so they can make decisions appropriate to their lives and value systems.

Entities:  

Mesh:

Year:  1992        PMID: 1480860     DOI: 10.1016/0749-2081(92)90042-2

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  6 in total

1.  Complexities in Cancer Risk Counseling: Presentation of Three Cases.

Authors:  K A Schneider; J E Stopfer; J A Peters; E Knell; G Rosenthal
Journal:  J Genet Couns       Date:  1997-06       Impact factor: 2.537

2.  Cancer Risk Counseling: How Is It Different?

Authors:  K A Schneider; D Marnane
Journal:  J Genet Couns       Date:  1997-06       Impact factor: 2.537

3.  The Familial Cancer Program of the Vermont Cancer Center: Development of a Cancer Genetics Program in a Rural Area.

Authors:  W C McKinnon; A E Guttmacher; M S Greenblatt; B E Compas; S May; R E Cutler; D W Yandell
Journal:  J Genet Couns       Date:  1997-06       Impact factor: 2.537

4.  An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling.

Authors:  K A Metcalfe; A Liede; E Hoodfar; A Scott; W D Foulkes; S A Narod
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

5.  Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling.

Authors:  A Liede; K Metcalfe; D Hanna; E Hoodfar; C Snyder; C Durham; H T Lynch; S A Narod
Journal:  Am J Hum Genet       Date:  2000-11-03       Impact factor: 11.025

6.  A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer.

Authors:  K G Macdonald; B Doan; M Kelner; K M Taylor
Journal:  CMAJ       Date:  1996-02-15       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.